https://www.nxtpsychedelics.com/news/articles/public-companies/tryp-therapeutics-strengthens-intellectual-property-portfolio-with-provisional-patent-applications-for-fibromyalgia-treatment-and-for-crystalline-forms-of-trp-8803/